Loading...
Heart Test Laboratories, Inc.
HSCS•NASDAQ
Healthcare
Medical - Devices
$4.001
$-0.37(-8.45%)
Heart Test Laboratories, Inc. (HSCS) Financial Performance & Statements
Review Heart Test Laboratories, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
261.17%
↑ 261.17%
Operating Income Growth
-3.15%
↓ 3.15%
Net Income Growth
98.65%
↑ 98.65%
Operating Cash Flow Growth
-5.14%
↓ 5.14%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-174.83%
↓ 174.83%
ROIC
-111483.03%
↓ 111483.03%
Heart Test Laboratories, Inc. (HSCS) Financial Statements
Explore quarterly and annual reports for Heart Test Laboratories, Inc. stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $33318.00 | $9201.00 |
| Gross Profit | $0.00 | $0.00 | -$33318.00 | -$9201.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $1.03B | $1.20M | $1.22M | $1.05M |
| SG&A Expenses | $1.34B | $786068.00 | $850736.00 | $833678.00 |
| Operating Expenses | $2.37B | $1.99M | $2.04M | $1.88M |
| Total Costs & Expenses | $0.00 | $1.99M | $2.08M | $1.88M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$179.48M | $117598.00 | $22526.00 | $20937.00 |
| Depreciation & Amortization | $0.00 | -$1.98B | $33318.00 | $76442.00 |
| EBITDA | -$2.37B | -$1.99B | -$2.00M | -$1.82M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$2.37B | -$1.99M | -$2.08M | -$1.88M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$164.82M | -$2.08B | $23978.00 | $33626.00 |
| Income Before Tax | -$2.54B | -$2.08B | -$2.05M | -$1.85M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $75500.00 |
| Net Income | -$2.54B | -$2.08M | -$2.05M | -$1.85M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$2572.16 | -$2.27 | -$2.64 | -$2.73 |
| Diluted EPS | -$2572.16 | -$2.27 | -$2.64 | -$2.73 |
| Weighted Avg Shares Outstanding | $98.61M | $91.74M | $77.77M | $67.66M |
| Weighted Avg Shares Outstanding (Diluted) | $98.61M | $91.74M | $77.77M | $67.66M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan